Anonymous: "AnaptysBio Announces Development of Novel Anti-IL33 Therapeutic Antibody | AnaptysBio", , 10 January 2014 (2014-01-10), XP055126733, Retrieved from the Internet: URL:http://www.anaptysbio.com/anti-il33/ [retrieved on 2014-07-03] (B1)

FOO Y LIEW ET AL: "Disease-associated functions of IL-33: the new kid in the IL-1 family", NATURE REVIEWS. IMMUNOLOGY, NATURE PUBLISHING GROUP, UNITED KINGDOM, vol. 10, no. 2, 1 February 2010 (2010-02-01), pages 103-110, XP002658775, ISSN: 1474-1741, DOI: 10.1038/NRI2692 [retrieved on 2010-01-18] (B1)

H. HAYAKAWA ET AL: "Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 36, 1 January 2007 (2007-01-01), pages 26369-26380, XP055030354, ISSN: 0021-9258, DOI: 10.1074/jbc.M704916200 (B1)

MINGCAI LI ET AL: "IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice", JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, vol. 247, no. 1, 19 March 2012 (2012-03-19), pages 25-31, XP028486570, ISSN: 0165-5728, DOI: 10.1016/J.JNEUROIM.2012.03.016 [retrieved on 2012-03-25] (B1)

WO-A2-2005/079844 (B1)

PALMER GABY ET AL: "Interleukin-33 biology with potential insights into human diseases", NATURE REVIEWS. RHEUMATOLOGY, NATURE PUBL. GROUP, USA, vol. 7, no. 6, 1 June 2011 (2011-06-01), pages 321-329, XP009178467, ISSN: 1759-4804 (B1)

R. KAMEKURA ET AL: "The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis", CLINICAL & EXPERIMENTAL ALLERGY : JOURNAL OF THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY, vol. 42, no. 2, 1 February 2012 (2012-02-01), pages 218-228, XP055510079, UK ISSN: 0954-7894, DOI: 10.1111/j.1365-2222.2011.03867.x & Anonymous: "Human ST2/IL-33 R Antibody Monoclonal Mouse IgG1 Clone # 97203 Catalog Number: MAB523", , 26 September 2018 (2018-09-26), XP055510080, Retrieved from the Internet: URL:https://resources.rndsystems.com/pdfs/ datasheets/mab523.pdf [retrieved on 2018-09-26] (B1)

Uniprot: "Alignment human and cynomolgus monkey IL-33", , 3 August 2017 (2017-08-03), XP055396027, Retrieved from the Internet: URL:http://www.uniprot.org/align/A20170803 AAFB7E4D2F1D05654627429E83DA5CCEC7E4343 [retrieved on 2017-08-03] (B1)

PALMER G ET AL: "The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33", CYTOKINE, ACADEMIC PRESS LTD, PHILADELPHIA, PA, US, vol. 42, no. 3, 1 June 2008 (2008-06-01), pages 358-364, XP022696634, ISSN: 1043-4666, DOI: 10.1016/J.CYTO.2008.03.008 [retrieved on 2008-05-02] (B1)